Drugs which lower seizure threshold, especially phenothiazine derivatives, including those used for their antihistaminic or antinauseant properties, should not be used with Optiray.
Renal toxicity has been reported in a few patients with liver dysfunction who were given oral cholecystographic agents followed by intravascular contrast agents. Therefore administration of a contrast agent should be postponed by at least 48 hours following use of an oral cholecystographic agent.
Repeat Procedures: If in the clinical judgment of the physician a repeat examination is required, an interval of 5 days between procedures is recommended.
Special precautions, to be observed when performing specific diagnostic procedures, are listed in Dosage & Administration, under individual paragraphs pertaining to said specific procedures.
Sign Out